TSX
1D %
YTD %
33,584.34
0.7%
5.3%
TSXV
1D %
YTD %
995.76
2.4%
0.3%
S&P 500
1D %
YTD %
7,138.80
0.5%
4.1%
NASDAQ
1D %
YTD %
24,663.80
0.9%
6.2%
US 10Y
1D
YTD
4.34
0 bps
17 bps
DJIA
1D %
YTD %
49,141.93
0.1%
1.6%
CA 10Y
1D
YTD
3.51
1 bp
7 bps
CAD/USD
1D %
YTD %
0.731
0.4%
0.3%

WHAT'S ON TAP

HOT OFF THE PRESS

Update brings lower deficit, more spending

The Spring Economic Update was released after the close yesterday, bringing with it a revised fiscal deficit projection of $67B - down from $78B…

… on the back of higher nominal GDP and oil prices. Another ~$55B of spending was layered in since the initial budget, including a ~$6B package aimed at adding 80-100K Red Seal trades workers over five years

… in industries that align with Carney’s agenda. Reinforcing that agenda is the new $25B Canada Strong Fund, which looks set to be seeded via borrowing and grown through asset monetization and retail involvement… interesting.

ARC Resources gets taken out for $22B

ARC Resources (ARX) announced it’s being taken out by Shell for ~$22B, a near-30% premium - but roughly in-line with where the stock has traded historically…

… given recent pressure from pulled production guidance at Attachie. Shell management expects $250M of run-rate synergies from the addition of ARC’s liquids-heavy portfolio…

… making it the third largest Montney producer and driving a bid for peers with exposure to the basin. With growing confidence in LNG Canada Phase 2…

… enhanced cash flow profiles from supply disruptions, and modest valuations…

this might not be the last energy deal we see this year.

ON OUR RADAR

GAINERS & LOSERS

Gatekeeper (GSI)
1D %
YTD %
1.51
8.6%
18.4%
Celestica (CLS)
1D %
YTD %
493.22
14.5%
21.5%
Haivision (HAI)
1D %
YTD %
6.98
6.9%
33.2%
Blue Ant (BAMI)
1D %
YTD %
6.48
5.8%
17.8%
TFI Int. (TFII)
1D %
YTD %
197.81
4.9%
39.4%
Cameco (CCO)
1D %
YTD %
159.19
5.2%
26.7%

Celestica (CLS) fell nearly 15% on Q1 results that met top line estimates, beat small on EPS, and came with a $2B bump to the full-year revenue guide. Great numbers, but the new $19B target is back-half weighted

… with Q2 shaping up to deliver mid-single digit sequential growth, likely due to industry-wide supply constraints for a number of key components.

We are experiencing more component shortages now than 90 days ago. 2 main factors. One is the demand really continues to grow. And as a result, the suppliers are a little behind on adding capacity.

Robert Mionis (CEO) - Q1/26 call

Management is addressing these challenges by meaningfully building inventory balances and extending procurement cycles out to 2028

… supported by customer commitments, which give the company even greater revenue visibility and should keep the stock at a premium.

TFI International (TFII) gained 5% on the back of its Q1 results, which beat small on revenue and bigger on profit - with management showing some cautious optimism around an end market recovery

… driven by tighter supply in truckload and a potential return to organic growth in the Less-Than-Truckload (LTL) segment. The US market recovery appears more pronounced so far

… driving a larger re-rate than we’ve seen in peers like Mullen Group (MTL), given TFII’s greater exposure south of the border.

EARNINGS

YESTERDAY’S EARNINGS
Company Actual Consensus
🇨🇦 Toromont (TIH) 1.13 1.08
🇨🇦 Aecon (ARE) -0.21 -0.22
TODAY’S EARNINGS
Company Time Consensus
🇨🇦 Bausch (BLCO) AM 0.05
🇨🇦 Cdn National (CNR) AM 1.81
🇨🇦 CGI (GIB-A) AM 2.26
🇨🇦 Brookfield Infra (BIP) AM 0.20
🇨🇦 First Quantum (FM) AM 0.05
🇨🇦 Capital Power (CPX) AM 0.56
🇨🇦 Capstone (CS) PM 0.15
🇨🇦 Kinross (K) PM 0.73
🇨🇦 GFL Env. (GFL) PM 0.12
🇨🇦 Centerra (CG) PM 0.45
🇨🇦 Whitecap (WCP) PM 0.23
🇨🇦 AltaGas (ALA) PM 1.24

Was this forwarded to you? Join 10,000+ investors reading The Morning Meeting by clicking the button below.

You might be interested in…

Disclaimer: Content on this site, including research reports, is provided by Bullpen Finance Inc. for informational purposes only and does not constitute investment advice. Bullpen Finance Inc. receives compensation from issuers for research coverage; such compensation does not influence opinions expressed. For complete disclosures, please see our Legal & Disclosures section.